Imagine hearing your mother has been diagnosed with Amyotrophic Lateral Sclerosis (ALS)—more commonly known as Lou Gehrig’s disease. Between 2011 and 2014, almost 25,000 people in the United States died from it. While the disease has been diagnosed for decades, there is no known cure. With that in mind, imagine that after the doctors provide the diagnosis, they explain that although there are promising treatments being developed in clinical trials, none are available because the Food and Drug Administration’s (FDA) burdensome and onerous review process prevents them from being used.